Clinical Trial Update: A Study of CTD402 in T-ALL/LBL Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating CTD402 in patients with T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma
• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CTD402

Snippet

Sponsor: BIOHENG THERAPEUTICS US LLC | Conditions: Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic | Phase 1, Phase 2 | Status: RECRUITING